Charuhas Deshpande, MD
Associate Professor of Clinical Pathology and Laboratory Medicine
Department: Pathology and Laboratory Medicine
Contact information
Department of Pathology and Laboratory Medicine
3400 Spruce Street, Founders - 6.039
Philadelphia, PA 19104-4283
3400 Spruce Street, Founders - 6.039
Philadelphia, PA 19104-4283
Office: (215) 615-6523
Fax: (215) 349-5910
Fax: (215) 349-5910
Education:
MBBS
Grant Medical College, Mumbai, India, 1986.
MD (Pathology)
Tata Memorial Hospital - University of Bombay, Mumbai, India, 1990.
MD
New York State Education Department, 2009.
Permanent linkMBBS
Grant Medical College, Mumbai, India, 1986.
MD (Pathology)
Tata Memorial Hospital - University of Bombay, Mumbai, India, 1990.
MD
New York State Education Department, 2009.
Description of Clinical Expertise
Pulmonary and Mediastinal Pathology,Cardiovascular Pathology,
Description of Research Expertise
Neoplastic and non-neoplastic diseases of lung, pleura and thymus.Selected Publications
Abdeen S, Bdeir K, Abu-Fanne R, Maraga E, Higazi M, Khurram N, Feldman M, Deshpande C, Litzky LA, Heyman SN, Montone KT, Cines DB, Higazi AA.: Alpha-defensins: risk factor for thrombosis in COVID-19 infection. British Journal of Haematology 194(1): 44-52, July 2021.Bryski MG, Frenzel-Sulyok LG, Delikatny EJ, Deshpande C, Litzky LA, Singhal S.: Molecular imaging can identify the location to perform a frozen biopsy during intraoperative frozen section consultation. PLoS One 16(6): e0252731, June 2021.
Predina JD, Haas AR, Martinez M, O'Brien S, Moon EK, Woodruff P, Stadanlick J, Corbett C, Frenzel-Sulyok L, Bryski MG, Eruslanov E, Deshpande C, Langer C, Aguilar LK, Guzik BW, Manzanera AG, Aguilar-Cordova E, Singhal S, Albelda SM.: Neoadjuvant Gene-Mediated Cytotoxic Immunotherapy for Non-Small-Cell Lung Cancer: Safety and Immunologic Activity. Molecular Therapy 29(2): 658-670, February 2021.
Thompson JC, Davis C, Deshpande C, Hwang WT, Jeffries S, Huang A, Mitchell TC, Langer CJ, Albelda SM.: Gene signature of antigen processing and presentation machinery predicts response to checkpoint blockade in non-small cell lung cancer (NSCLC) and melanoma. J Immunother Cancer. 8(2): e000974, October 2020.
Bauml JM, Mick R, Ciunci C, Aggarwal C, Davis C, Evans T, Deshpande C, Miller L, Patel P, Alley E, Knepley C, Mutale F, Cohen RB, Langer CJ.: Pembrolizumab After Completion of Locally Ablative Therapy for Oligometastatic Non-Small Cell Lung Cancer: A Phase 2 Trial. JAMA Oncology 1(2): 1283-1290, Sep 2019.
Walter DM, Yates TJ, Ruiz-Torres M, Kim-Kiselak C, Gudiel AA, Deshpande C, Wang WZ, Cicchini M, Stokes KL, Tobias JW, Buza E, Feldser DM.: RB constrains lineage fidelity and multiple stages of tumour progression and metastasis. Nature 569(7756): 423-427, May 2019.
Predina JD, Keating J, Newton A, Corbett C, Xia L, Shin M, Frenzel Sulyok L, Deshpande C, Litzky L, Nie S, Kucharczuk JC, Singhal S.: A clinical trial of intraoperative near-infrared imaging to assess tumor extent and identify residual disease during anterior mediastinal tumor resection. Cancer 125(5): 807-817, March 2019.
Predina JD, Newton A, Corbett C, Xia L, Sulyok LF, Shin M, Deshpande C, Litzky L, Barbosa E, Low PS, Kucharczuk JC, Singhal S: Localization of Pulmonary Ground-Glass Opacities with Folate Receptor-Targeted Intraoperative Molecular Imaging. J Thorac Oncol. 13(7): 1028-1036, July 2018.
Predina JD, Newton AD, Xia L, Corbett C, Connolly C, Shin M, Sulyok LF, Litzky L, Deshpande C, Nie S, Kularatne SA, Low PS, Singhal S.: An open label trial of folate receptor-targeted intraoperative molecular imaging to localize pulmonary squamous cell carcinomas. Oncotarget 9(17): 13517-13529, March 2018.
Predina JD, Newton AD, Keating J, Dunbar A, Connolly C, Baldassari M, Mizelle J, Xia L, Deshpande C, Kucharczuk J, Low PS, Singhal S.: A Phase I Clinical Trial of Targeted Intraoperative Molecular Imaging for Pulmonary Adenocarcinomas. Ann Thorac Surg. 105(3): 901-908, March 2018.